TY - JOUR
T1 - Opinión de los expertos para optimizar el control y la telemedicina en pacientes con asma en era pospandémica
T2 - consenso COMETA
AU - Molina Paris, Jesús
AU - Almonacid Sánchez, Carlos
AU - Blanco-Aparicio, Marina
AU - Domínguez-Ortega, Javier
AU - Giner Donaire, Jordi
AU - Sánchez Marcos, Navidad
AU - Plaza, Vicente
N1 - Funding Information:
Authors would like to acknowledge GlaxoSmithKline (GSK) and employees – Alfonso Agra, Alfonso Martinez, Natalia Bartolomé, Almudena Blanco and Carolina Peña for their support to carry out this project. GSK provided funding for the research and inputted into the study design, questionnaire development and expert panel selection for data review and interpretation. GSK reviewed a draft of the publication for data accuracy only, but the final and published content is the authors’ sole work. Thanks as well to the scientific consultancy team of Adelphi Targis S.L. comprised of Ana Fernández and Montse Mestres, for their technical and editorial support at developing the COMETA consensus project, and to Jemina Moreto for medical writing support.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/12
Y1 - 2022/12
N2 - Objective: To collect perspectives and explore consensus for expert recommendations related to asthma control and the use of telemedicine among professionals who manage patients with asthma. Design: A Delphi-like questionnaire was designed to analyse the level of agreement about several recommendations formulated by an expert scientific committee about asthma control and the use of telemedicine with this purpose. A dedicated scientific committee validated the questionnaire, which included questions about the participants’ profile and the use of technological tools at a personal level or in clinical practice. The experts expressed their agreement with a Likert-scale of 9 values: 1–3 was considered no agreement, 4–6 neutral, and 7–9 agreement. A rate ≥70% with the same answer was considered consensus. Site: The questionnaire was programmed and distributed as an internet-based survey. Participants: A pre-selected sample of 75 experts with experience in telemedicine (pulmonology, allergology, family medicine, nursing and community pharmacy) responded to a Delphi-like questionnaire composed by six questions and 52 items. Interventions: Consultation was performed in two consecutive waves: the first wave was carried out from 12th of July to 8th of September of 2021; the second wave, from 25th of October to 12th of November of 2021. Main measurements: Three questions about asthma control (actions for achieving or maintaining control of asthma at every visit, current problems that affect asthma control, and potential solutions to offset such problems), and three questions about the impact of telemedicine in asthma control (potential benefits of telemedicine, and potential reticence about telemedicine among both patients and healthcare professionals) were included. Results: From the 52 items inquired, 35 were agreed by consensus. The actions for achieving or maintaining control of asthma, the problems that affect asthma control, and their potential solutions were agreed by consensus. The potential benefits of telemedicine were validated by consensus. None of the potential reservations of patients about telemedicine were validated, while five out of 14 potential reservations of healthcare professionals were agreed by consensus. Conclusions: The COMETA consensus provides a current picture of the main problems for achieving asthma control, the benefits and the reservations about the use of telemedicine in the Spanish setting, and offers solutions. A wide interest in implementing telemedicine has been observed, although current limitations need to be overcome.
AB - Objective: To collect perspectives and explore consensus for expert recommendations related to asthma control and the use of telemedicine among professionals who manage patients with asthma. Design: A Delphi-like questionnaire was designed to analyse the level of agreement about several recommendations formulated by an expert scientific committee about asthma control and the use of telemedicine with this purpose. A dedicated scientific committee validated the questionnaire, which included questions about the participants’ profile and the use of technological tools at a personal level or in clinical practice. The experts expressed their agreement with a Likert-scale of 9 values: 1–3 was considered no agreement, 4–6 neutral, and 7–9 agreement. A rate ≥70% with the same answer was considered consensus. Site: The questionnaire was programmed and distributed as an internet-based survey. Participants: A pre-selected sample of 75 experts with experience in telemedicine (pulmonology, allergology, family medicine, nursing and community pharmacy) responded to a Delphi-like questionnaire composed by six questions and 52 items. Interventions: Consultation was performed in two consecutive waves: the first wave was carried out from 12th of July to 8th of September of 2021; the second wave, from 25th of October to 12th of November of 2021. Main measurements: Three questions about asthma control (actions for achieving or maintaining control of asthma at every visit, current problems that affect asthma control, and potential solutions to offset such problems), and three questions about the impact of telemedicine in asthma control (potential benefits of telemedicine, and potential reticence about telemedicine among both patients and healthcare professionals) were included. Results: From the 52 items inquired, 35 were agreed by consensus. The actions for achieving or maintaining control of asthma, the problems that affect asthma control, and their potential solutions were agreed by consensus. The potential benefits of telemedicine were validated by consensus. None of the potential reservations of patients about telemedicine were validated, while five out of 14 potential reservations of healthcare professionals were agreed by consensus. Conclusions: The COMETA consensus provides a current picture of the main problems for achieving asthma control, the benefits and the reservations about the use of telemedicine in the Spanish setting, and offers solutions. A wide interest in implementing telemedicine has been observed, although current limitations need to be overcome.
KW - Asthma
KW - Consensus
KW - Delphi methodology
KW - Telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85140777535&partnerID=8YFLogxK
U2 - 10.1016/j.aprim.2022.102492
DO - 10.1016/j.aprim.2022.102492
M3 - Artículo
C2 - 36272223
AN - SCOPUS:85140777535
VL - 54
IS - 12
M1 - 102492
ER -